Mark L. Perry

Insider Reports History

Entity
Individual
Location
176 West Blithedale Ave, Mill Valley, CA
Signature
/s/ Rebecca Peters, Attorney-in-Fact for Mark L. Perry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark L. Perry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NVIDIA CORP Director Common Stock 116K $103M $887.89 Apr 2, 2024 By Trust
NVIDIA CORP Director Common Stock 13.6K $12.1M $887.89 Apr 2, 2024 Direct
NVIDIA CORP Director Common Stock 1K $888K $887.89 Apr 2, 2024 The Taylor William Perry 2023 Irrevocable Trust
NVIDIA CORP Director Common Stock 1K $888K $887.89 Apr 2, 2024 The Zoe Blue Perry 2020 Irrevocable Trust
Global Blood Therapeutics, Inc. Director Common Stock 0 $46.99 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Director Restricted Stock Units 0 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Oct 5, 2022 Direct

Insider Reports Filed by Mark L. Perry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVDA NVIDIA CORP Jun 26, 2024 0 $0 4 Jun 26, 2024 Director
NVDA NVIDIA CORP Apr 2, 2024 1 -$6.22M 4 Apr 3, 2024 Director
NVDA NVIDIA CORP Feb 23, 2024 1 -$11.9M 4 Feb 27, 2024 Director
NVDA NVIDIA CORP Jun 23, 2023 1 $0 4 Jun 27, 2023 Director
NVDA NVIDIA CORP May 26, 2023 3 $0 4 May 31, 2023 Director
NVDA NVIDIA CORP Feb 27, 2023 4 -$4.73M 4 Feb 28, 2023 Director
GBT Global Blood Therapeutics, Inc. Oct 5, 2022 7 $0 4 Oct 6, 2022 Director
GBT Global Blood Therapeutics, Inc. Jun 14, 2022 4 $0 4 Jun 16, 2022 Director
NVDA NVIDIA CORP Jun 3, 2022 1 $0 4 Jun 7, 2022 Director
NVDA NVIDIA CORP Mar 18, 2022 4 -$4.41M 4 Mar 21, 2022 Director
GBT Global Blood Therapeutics, Inc. Jun 17, 2021 4 $0 4 Jun 21, 2021 Director
NVDA NVIDIA CORP Jun 4, 2021 1 $0 4 Jun 8, 2021 Director